Missouri legislation · 2026 Regular Session
Missouri HB1881: Adds xylazine to the list of Schedule III controlled substances
Status: In committee, May 13, 2026
What the bill says
From the engrossed text:
SECOND REGULAR SESSION [PERFECTED] HOUSE BILL NO. 1881 103RD GENERAL ASSEMBLY INTRODUCED BY REPRESENTATIVE ALLEN. 4059H.01P JOSEPH ENGLER, Chief Clerk To repeal section 195.017, RSMo, and to enact in lieu thereof one new section relating to controlled substances. Section A. Section 195.017, RSMo, is repealed and one new section enacted in lieu thereof, to be known as section 195.017, to read as follows: 195.017. 1. The department of health and senior services shall place a substance in Schedule I if it finds that the and (2) Has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision. 2. Schedule (2) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation: (a) Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl)-Nphenylacetamide); (b) Acetylmethadol; (c) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); (d) Acryl fentanyl (-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide); EXPLANATION -- Matter enclosed in bold-faced brackets [thus] in the above bill is not enacted and is intended to be omitted from the law. Matter in bold-face type in the above bill is proposed language. HB 1881 (e) AH-7921(3,4-dichloro-N-[(1-dimethylamino) cyclohexylmethyl] benzamide); (f) Allylprodine; (g) Alphacetylmethadol (except levoalphacetylmethadol, also known as levo-alphaacetylmethadol levothadyl acetate or LAAM); (h) Alphameprodine; (i) …
Sponsors
- Bill Allen (R, 017) · primary sponsor
- Burt Whaley (R, 138)
- Carolyn Caton (R, 033)
- John Hewkin (R, 120)
Latest actions
- : Dropped from Calendar - Pursuant to House Rules (H)
- : Placed on the Informal Third Reading Calendar (H)
- : Placed Back on Third Reading Calendar (H)
- : Reported Do Pass (H) - AYES: 6 NOES: 1 PRESENT: 0
- : Voted Do Pass (H)
- : Executive Session Completed (H)
- : Placed on the Informal Third Reading Calendar (H)
- : Referred: Fiscal Review(H)
- : Perfected (H)
- : Title of Bill - Agreed To
Votes
- Reported Do Pass (H) (April 8, 2026): 6 yea, 1 nay, passed
- Reported Do Pass (H) (March 30, 2026): 9 yea, 1 nay, passed
- Reported Do Pass (H) (February 26, 2026): 10 yea, 0 nay, passed
Common questions
- What is HB1881?
- HB1881 is a bill in the Missouri Legislature (2026 Regular Session): Adds xylazine to the list of Schedule III controlled substances.
- What is the status of HB1881?
- In committee as of May 13, 2026. Latest action: Dropped from Calendar - Pursuant to House Rules (H) (May 13, 2026).
- Who sponsored HB1881?
- Bill Allen (R, 017), with 3 co-sponsors.
- Where is the official record for HB1881?
- On the Missouri Legislature website: https://house.mo.gov/BillContent.aspx?bill=HB1881&year=2026&code=R
Source: official Missouri record. Tracked by Delilah, AI for legislation across all 50 states and Congress.